Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges.

Journal of the American Heart Association
Clémence GraveValérie Olié

Abstract

Background Aortic stenosis (AS) is one of the most common forms of valvular heart disease. Our aim was to estimate the burden of AS in the hospital in France, describe patient characteristics, and evaluate the mortality rate and temporal trends. Methods and Results All patients hospitalized for AS in France between 2006 and 2016 were identified from the national hospital discharge database. Patients' sociodemographic, medical, and surgical characteristics and temporal trends were described. All AS-related deaths between 2000 and 2014 were identified using death certificates. In 2016, 26 071 patients were hospitalized for AS: 56.5% were men with an average age of 77 years. The all-cause mortality rate at 1 year postindex stay was 11%. The rate of patients hospitalized for AS increased by 59% between 2006 and 2016, reaching 38.7/100 000 person-years in 2016. This increase was most pronounced in patients aged >75 years. The number of transcatheter aortic valve implantations increased following their introduction in 2010. In 2016, 44% of patients were treated with aortic valve surgery during the index hospital stay or following year (mean age, 71.5 years), and 34% were treated with transcatheter aortic valve implantation (mean age,...Continue Reading

References

Mar 1, 1997·Journal of the American College of Cardiology·B F StewartC M Otto
Jul 15, 1999·The New England Journal of Medicine·C M OttoD S Siscovick
Sep 19, 2006·Lancet·Vuyisile T NkomoMaurice Enriquez-Sarano
Jul 6, 2010·Revue D'épidémiologie Et De Santé Publique·P TuppinY Merlière
Oct 22, 2010·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER Trial Investigators
Mar 13, 2012·Lancet·Eloi MarijonXavier Jouven
Aug 28, 2012·European Heart Journal·UNKNOWN Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)Marian Zembala
Sep 4, 2012·Heart·Gry Wisthus EvebornKnut Rasmussen
May 20, 2014·Progress in Cardiovascular Diseases·Jeremy J ThadenMaurice Enriquez-Sarano
Jul 6, 2014·The Canadian Journal of Cardiology·Bernard Iung, Alec Vahanian
Dec 31, 2014·La Revue de médecine interne·G MoulisL Sailler
Nov 7, 2015·Heart·Sean CoffeyBernard Iung
Apr 5, 2016·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER 2 Investigators
Aug 3, 2016·The American Journal of Cardiology·Hind A BeydounShaker M Eid
Dec 14, 2016·Journal of the American College of Cardiology·Frederick L GroverUNKNOWN STS/ACC TVT Registry
Jul 1, 2017·Journal of the American College of Cardiology·Vincent AuffretUNKNOWN FRANCE TAVI Investigators
Aug 24, 2017·The New England Journal of Medicine·David A WatkinsGregory A Roth
Sep 10, 2017·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Scientific Document Group
Nov 14, 2018·The Annals of Thoracic Surgery·Richard S D'AgostinoDavid M Shahian
Feb 13, 2019·The American Journal of Cardiology·Ho Jin KimSeung-Jung Park
Mar 8, 2019·Journal of the American Heart Association·Geraud DelesalleChristophe Tribouilloy
Mar 19, 2019·The New England Journal of Medicine·Jeffrey J PopmaUNKNOWN Evolut Low Risk Trial Investigators
Mar 19, 2019·The New England Journal of Medicine·Michael J MackUNKNOWN PARTNER 3 Investigators
Jun 12, 2019·JAMA : the Journal of the American Medical Association·Graham H BevanSadeer G Al-Kindi
Jul 7, 2019·The American Journal of Cardiology·Andrew M GoldsweigJ Dawn Abbott

❮ Previous
Next ❯

Citations

Jul 23, 2021·International Journal of Cardiology·Caterina MaffeisPompilio Faggiano

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.